DE69127545D1 - Liposomen, die versorgt werden mit t-helfer lympozyten zur unterstützung schwacher antigene als impfstoffe - Google Patents

Liposomen, die versorgt werden mit t-helfer lympozyten zur unterstützung schwacher antigene als impfstoffe

Info

Publication number
DE69127545D1
DE69127545D1 DE69127545T DE69127545T DE69127545D1 DE 69127545 D1 DE69127545 D1 DE 69127545D1 DE 69127545 T DE69127545 T DE 69127545T DE 69127545 T DE69127545 T DE 69127545T DE 69127545 D1 DE69127545 D1 DE 69127545D1
Authority
DE
Germany
Prior art keywords
helper
liposomes
lympocytes
antique
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69127545T
Other languages
English (en)
Other versions
DE69127545T2 (de
Inventor
Howard R Six
Nathalie Garcon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Development Foundation
Original Assignee
Research Development Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Development Foundation filed Critical Research Development Foundation
Publication of DE69127545D1 publication Critical patent/DE69127545D1/de
Application granted granted Critical
Publication of DE69127545T2 publication Critical patent/DE69127545T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69127545T 1990-07-27 1991-07-24 Liposomen, die versorgt werden mit t-helfer lympozyten zur unterstützung schwacher antigene als impfstoffe Expired - Fee Related DE69127545T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55896090A 1990-07-27 1990-07-27
PCT/US1991/005231 WO1992002243A1 (en) 1990-07-27 1991-07-24 Liposomes that provide thymic dependent help to weak vaccine antigens

Publications (2)

Publication Number Publication Date
DE69127545D1 true DE69127545D1 (de) 1997-10-09
DE69127545T2 DE69127545T2 (de) 1998-01-08

Family

ID=24231699

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69127545T Expired - Fee Related DE69127545T2 (de) 1990-07-27 1991-07-24 Liposomen, die versorgt werden mit t-helfer lympozyten zur unterstützung schwacher antigene als impfstoffe

Country Status (22)

Country Link
US (1) US5464630A (de)
EP (1) EP0542923B1 (de)
JP (1) JP3518866B2 (de)
KR (1) KR100213851B1 (de)
CN (1) CN1032236C (de)
AT (1) ATE157537T1 (de)
AU (1) AU650299B2 (de)
CA (1) CA2088163C (de)
DE (1) DE69127545T2 (de)
DK (1) DK0542923T3 (de)
ES (1) ES2106088T3 (de)
FI (1) FI107515B (de)
GR (1) GR3025377T3 (de)
HK (1) HK1008304A1 (de)
IE (1) IE912535A1 (de)
IL (1) IL98935A (de)
NO (1) NO311167B1 (de)
NZ (1) NZ239072A (de)
PT (1) PT98470B (de)
RU (1) RU2107493C1 (de)
WO (1) WO1992002243A1 (de)
ZA (1) ZA915755B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879685A (en) * 1991-05-08 1999-03-09 Schweiz, Serum- & Impfinstitut Bern Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
US6004534A (en) * 1993-07-23 1999-12-21 Massachusetts Institute Of Technology Targeted polymerized liposomes for improved drug delivery
WO1996007102A1 (en) * 1994-09-01 1996-03-07 Wisconsin Alumni Research Foundation Therapeutic remodeling in aids
US6060082A (en) * 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
AUPO732997A0 (en) * 1997-06-12 1997-07-03 Csl Limited Ganglioside immunostimulating complexes and uses thereof
US5993852A (en) * 1997-08-29 1999-11-30 Pharmaderm Laboratories Ltd. Biphasic lipid vesicle composition for transdermal administration of an immunogen
US6027731A (en) * 1998-11-17 2000-02-22 Wisconsin Alumni Research Foundation Pertussis toxin induced lymphocytosis
CN102294023A (zh) * 2001-07-26 2011-12-28 奥塔戈创新公司 抗原组合物
WO2007039584A1 (en) 2005-09-30 2007-04-12 Lipoxen Technologies Limited Multivalent liposomal vaccine compositions comprising polysaccharide antigens and a protein adjuvant
RU2480479C1 (ru) * 2011-11-01 2013-04-27 Елена Викторовна Свирщевская Гетерологичный пептидный мини-антиген в составе полимерной частицы для создания противоаллергенной вакцины
CA2860599C (en) 2012-01-03 2021-07-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Native and agonist ctl epitopes of the muc1 tumor antigen
US10035832B2 (en) 2013-10-23 2018-07-31 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use
EP3331554B1 (de) 2015-08-03 2022-05-11 The U.S.A. as represented by the Secretary, Department of Health and Human Services Brachyury-deletionsmutanten, nichthefevektoren zur codierung von brachyury-deletionsmutanten und verwendung davon
WO2018085751A1 (en) 2016-11-07 2018-05-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Development of agonist epitopes of the human papillomavirus
WO2020102404A1 (en) 2018-11-14 2020-05-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Tp5, a peptide inhibitor of aberrant and hyperactive cdk5/p25 as treatment for cancer
US20230287067A1 (en) 2020-01-21 2023-09-14 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services Human immunogenic epitopes of hemo and hhla2 human endogenous retroviruses (hervs)
WO2021150713A2 (en) 2020-01-21 2021-07-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Human immunogenic epitopes of h, k, and e human endogenous retroviruses (hervs)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009343C3 (de) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Lysolecithinen als immunologische Adjuvantien
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
US4196191A (en) * 1975-09-29 1980-04-01 Burroughs Wellcome Co. Biological preparations
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
GB2026340B (en) * 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
HU184141B (en) * 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4565696A (en) * 1983-08-03 1986-01-21 The Regents Of The University Of California Production of immunogens by antigen conjugation to liposomes
US4708933A (en) * 1984-06-12 1987-11-24 Leaf Huang Immunoliposome assay-methods and products
CA1267087A (en) * 1985-02-14 1990-03-27 Nicolaas Visser Synthetic immunogen
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
US4882145A (en) * 1986-12-09 1989-11-21 Scripps Clinic And Research Foundation T cell epitopes of the hepatitis B virus nucleocapsid protein
AU626797B2 (en) * 1987-09-08 1992-08-13 Albany Medical College Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production

Also Published As

Publication number Publication date
IL98935A0 (en) 1992-07-15
AU8759791A (en) 1992-03-02
CN1059279A (zh) 1992-03-11
NO311167B1 (no) 2001-10-22
ES2106088T3 (es) 1997-11-01
IL98935A (en) 1994-01-24
EP0542923A1 (de) 1993-05-26
PT98470B (pt) 1998-02-27
IE912535A1 (en) 1992-01-29
WO1992002243A1 (en) 1992-02-20
RU2107493C1 (ru) 1998-03-27
DE69127545T2 (de) 1998-01-08
CA2088163C (en) 2003-06-17
EP0542923A4 (de) 1994-04-13
NZ239072A (en) 1997-06-24
JPH06502630A (ja) 1994-03-24
CA2088163A1 (en) 1992-01-28
GR3025377T3 (en) 1998-02-27
FI930319A (fi) 1993-01-26
DK0542923T3 (da) 1997-10-13
NO930202D0 (no) 1993-01-21
AU650299B2 (en) 1994-06-16
ZA915755B (en) 1993-02-24
US5464630A (en) 1995-11-07
FI930319A0 (fi) 1993-01-26
PT98470A (pt) 1992-06-30
FI107515B (fi) 2001-08-31
EP0542923B1 (de) 1997-09-03
ATE157537T1 (de) 1997-09-15
JP3518866B2 (ja) 2004-04-12
NO930202L (no) 1993-01-21
CN1032236C (zh) 1996-07-10
KR100213851B1 (ko) 1999-08-02
HK1008304A1 (en) 1999-05-07

Similar Documents

Publication Publication Date Title
DE69127545D1 (de) Liposomen, die versorgt werden mit t-helfer lympozyten zur unterstützung schwacher antigene als impfstoffe
DK0673429T3 (da) Fremstilling af heterologe proteiner i filamentøse svampe
ES2115626T3 (es) Anticuerpo monoclonal humano especifico al antigeno de superficie de la membrana de las celulas cancerosas.
HU9500571D0 (en) Retro-, inverso-, and retro-inverso synthetic peptide analogues
AU5055593A (en) Antibodies specific for HIV
RU93004915A (ru) Липосомы, осуществляющие тимус-зависимую помощь "слабым" антигенам, используемым для приготовления вакцины
BR9809656A (pt) Composição imunopotencializante
DE3879803D1 (de) Reinigung von faktor viii:c durch phospholipid-affinitaet.
ES2196150T3 (es) Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion.
GB9406492D0 (en) Malaria peptides
ATE114713T1 (de) Biomasse zur produktion von virus/virusantigen.
IE792390L (en) Hepatitis be antigen.
ATE109834T1 (de) Monoklonaler antikörper spezifisch gegen humane pankreas-phospholipase-a2.
DE69301733D1 (de) Impfstoffe gegen Metazoen-Parasiten
ATE109004T1 (de) Toleranzinduktion gegenüber einem fremdantigen.
DE69617255D1 (de) Durch hla-b44 moleküle präsentierte tumor-abstossungsantigene und ihre verwendung
EP0314993A3 (de) 1,7,9,15-Tetraoxa-4,12-diaza-8-silaspiro-[7.7]-pentadecane, Verfahren zu ihrer Herstellung und ihre Verwendung
DK0570682T3 (da) Syntetiske lipid-A-glycoconjugat-antigener til anvendelse i vacciner
ES2051870T3 (es) Anticuerpo monoclonal capaz de suprimir la proliferacion de linfocitos t.
IT1254147B (it) Metodo di rivelazione di marcatori tumorali.
IT9043522A0 (it) Pendolo circolare accelerato dal galleggiante

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee